HCWB - HCW Biologics Inc.
0.6201
-0.010 -1.580%
Share volume: 92,499
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$0.63
-0.01
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-14-2024 | 11-14-2024 | 03-28-2025 | 05-15-2025 | 11-14-2025 | |
| Total revenue | 1.127 M | 618.854 K | 426.423 K | 394.803 K | 5.065 K | 15.606 K | |
| Cost of revenue | 511.965 K | 438.443 K | 341.138 K | 315.843 K | 4.052 K | 12.485 K | |
| Gross profit | 614.747 K | 180.411 K | 85.285 K | 78.960 K | 1.013 K | 3.121 K | |
| -70.65% | -52.73% | -7.42% | -98.72% | 208.09% | |||
| Operating expenses | 8.108 M | 3.623 M | 2.826 M | -1.329 M | 3.706 M | 3.289 M | |
| Selling general and admin | 5.985 M | 1.594 M | 1.639 M | -2.379 M | 2.228 M | 1.885 M | |
| Research and development | 2.123 M | 2.029 M | 1.187 M | 1.050 M | 1.479 M | 1.404 M | |
| Total expenses | 8.108 M | 15.316 M | 3.776 M | 3.239 M | 1.967 M | 3.295 M | |
| 88.90% | -75.35% | -14.22% | -39.27% | 67.54% | |||
| Operating income | -7.494 M | -15.136 M | -3.690 M | -3.160 M | -1.966 M | -3.292 M | |
| Ebit | -7.468 M | -15.121 M | -3.679 M | -3.125 M | -1.941 M | -4.245 M | |
| Pretax income | -7.468 M | -15.280 M | -3.902 M | -3.373 M | -2.197 M | -4.372 M | |
| 104.61% | -74.46% | -13.56% | -34.87% | 99.02% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -7.468 M | -15.280 M | -3.902 M | -3.373 M | -2.197 M | -4.554 M | |
| -104.61% | 74.46% | 13.56% | 34.87% | -107.31% |